Lab School Day Study for CONCERTA of Older Children With ADHD

Completed · Phase 4 · Has a placebo group

Conditions studied: Attention Deficit Hyperactivity Disorder

In brief

The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with attention deficit hyperactivity disorder (ADHD), when compared to placebo.

Key facts

Study ID
NCT00799409
Run by
Ortho-McNeil Janssen Scientific Affairs, LLC
People needed
78
Starts
2008-12-01
Expected to finish
2009-06-01
Last updated by the study team
2014-05-09

Who can join

Age: 9 and older, up to 12. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.